Ep. 64: “Brain Tumor Immunotherapy” Featuring Dr. Peter Fecci

Guest:

Dr. Peter Fecci is a Professor of Neurosurgery at Duke University and the Director of the Duke Center for Brain and Spine Metastasis. His research focuses on brain tumor immunology and immunotherapy, and T cell dysfunction in glioblastoma and other intracranial cancers. He talks about activating T cells to target brain tumors and his team’s work on targeting MHC-I-negative tumor cells.

Featured Products and Resources:

• Register now for the International Congress of Immunology in South Africa!
• Keep current with the latest in neural cell news.

The Immunology Science Round Up

A Universal Flu Vaccine Candidate – A group 2 hemagglutinin universal influenza virus vaccine candidate protects mice against group 2 influenza viruses.

Regulatory T Cells in Muscle Function – Exercise induces a highly functional and stable muscle Treg phenotype.

An Antiviral Drug and SARS-CoV-2 Mutations – Scientists identified a mutational spectrum from viruses in patients treated with molnupiravir.

Microbial Exposure and Allergic Inflammation – Increased microbial biodiversity in mice does not protect against allergic inflammation, in contrast to what would be predicted by the hygiene hypothesis.

Image courtesy of Dr. Peter Fecci

Subscribe to our newsletter!

Never miss updates about new episodes.

Subscribe